Patents by Inventor Matthew R. Kaser
Matthew R. Kaser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20150017173Abstract: The invention provides human transmembrane proteins (HTMPN) and polynucleotides which identify and encode HTMPN. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HTMPN.Type: ApplicationFiled: August 28, 2014Publication date: January 15, 2015Applicant: Incyte CorporationInventors: Y. Tom Tang, Preeti G. Lal, Jennifer L. Jackson, Henry Yue, Karl J. Guegler, Neil C. Corley, Olga Bandman, Chandra S. Arvizu, Gina A. Gorgone Simone, Matthew R. Kaser, Mariah R. Baughn, Janice K. Au-Young
-
Publication number: 20120270809Abstract: The invention provides human transmembrane proteins (HTMPN) and polynucleotides which identify and encode HTMPN. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HTMPN.Type: ApplicationFiled: May 22, 2012Publication date: October 25, 2012Inventors: Y. Tom Tang, Preeti Lal, Jennifer L. Hillman, Henry Yue, Karl J. Guegler, Neil C. Corley, Olga Bandman, Chandra Patterson, Gina A. Gorgone, Matthew R. Kaser, Mariah R. Baughn, Janice Au-Young
-
Patent number: 8206947Abstract: The invention provides human transmembrane proteins (HTMPN) and polynucleotides which identify and encode HTMPN. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HTMPN.Type: GrantFiled: November 8, 2006Date of Patent: June 26, 2012Assignee: Incyte CorporationInventors: Y. Tom Tang, Preeti G. Lal, Jennifer L. Jackson, Henry Yue, Karl J. Guegler, Neil C. Corley, Olga Bandman, Chandra S. Arvizu, Gina A. Gorgone Simone, Matthew R. Kaser, Mariah R. Baughn, Janice K. Au-Young
-
Publication number: 20040265891Abstract: The invention provides a polypeptide which encodes human presenilin variant. It also provides for the use of the cDNA and protein in the diagnosis, prognosis, treatment and evaluation of therapies for cancer or neurodegenerative or immune disorders. The invention further provides vectors and host cells for the production of the protein and transgenic model systems.Type: ApplicationFiled: July 12, 2004Publication date: December 30, 2004Applicant: Incyte Genomics, Inc.Inventors: Chandra Arvizu, Lynn E. Murry, Matthew R. Kaser
-
Patent number: 6783955Abstract: The invention provides a cDNA which encodes human presenilin variant. It also provides for the use of the cDNA and protein in the diagnosis, prognosis, treatment and evaluation of therapies for cancer or neurodegenerative or immune disorders. The invention further provides vectors and host cells for the production of the protein and transgenic model systems.Type: GrantFiled: June 29, 2001Date of Patent: August 31, 2004Assignee: Incyte CorporationInventors: Chandra Arvizu, Lynn E. Murry, Matthew R. Kaser
-
Patent number: 6727066Abstract: The present invention relates to a composition comprising a plurality of cDNAs which are differentially expressed in treated human C3A liver cell cultures and which may be used entirely or in part to diagnose, to stage, to treat, or to monitor the progression or treatment of liver disorders such as hyperlipidemia.Type: GrantFiled: July 30, 2001Date of Patent: April 27, 2004Assignee: Incyte CorporationInventor: Matthew R. Kaser
-
Publication number: 20040058358Abstract: The invention provides a mammalian nucleic acid and fragments thereof. It also provides for the use of these nucleic acids in a model system for the characterization, diagnosis, evaluation, treatment of conditions, diseases and disorders associated with expression of the mammalian nucleic acid. The invention additionally provides expression vectors and host cells for the production of the protein encoded by the mammalian nucleic acid.Type: ApplicationFiled: May 21, 2003Publication date: March 25, 2004Applicant: Incyte CorporationInventors: Henry Yue, Matthew R. Kaser, Mariah R. Baughn
-
Patent number: 6692923Abstract: The invention provides a cDNA which encodes tapasin-like protein. It also provides for the use of the cDNA, protein, and antibody in the diagnosis, prognosis, treatment and evaluation of therapies for cancer. The invention further provides vectors and host cells for the production of the protein and transgenic model systems.Type: GrantFiled: August 20, 2001Date of Patent: February 17, 2004Assignee: Incyte CorporationInventors: Preeti G. Lal, Matthew R. Kaser, Mariah R. Baughn
-
Publication number: 20040005559Abstract: The invention provides cDNAs that are diagnostic of and participate in neuronal differentiation and morphogenesis, proteins encoded by the cDNAs and agonists, antagonists, and antibodies that specifically bind the protein. The invention also provides compositions containing cDNAs, proteins, or antibodies and methods for their use diagnostically and therapeutically.Type: ApplicationFiled: January 30, 2002Publication date: January 8, 2004Inventors: Jeanne F. Loring, Matthew R. Kaser
-
Publication number: 20030194721Abstract: The invention relates to isolated polynucleotides, purified polypeptides, and compositions comprising pluralities of polynucleotides that are differentially expressed when foam cells are treated with oxidized low-density lipoprotein and LPS as associated with atherosclerosis. The invention also presents the use of the polynucleotides as elements on a substrate and provides methods for using the polynucleotides and polypeptides.Type: ApplicationFiled: September 18, 2002Publication date: October 16, 2003Applicant: Incyte Genomics, Inc.Inventors: Thomas Mikita, Dov Shiffman, J. Gordon Porter, Matthew R. Kaser
-
Publication number: 20030175787Abstract: The invention provides mammalian cDNAs which encode mammalian vesicle membrane proteins. It also provides for the use of the cDNAs, fragments, complements, and variants thereof and of the encoded proteins, portions thereof and antibodies thereto for diagnosis and treatment of cell proliferative disorders, particularly cancers of the colon, breast, ovary, uterus, prostate, adrenal gland, and thyroid, and thyroid follicular adenoma and thyroid lymphocytic thyroiditis. The invention additionally provides expression vectors and host cells for the production of the proteins and transgenic model systems.Type: ApplicationFiled: March 19, 2003Publication date: September 18, 2003Applicant: Incyte CorporationInventors: Jennifer L. Hillman, Henry Yue, Preeti Lal, Matthew R. Kaser
-
Publication number: 20030165854Abstract: The present invention relates to a combination comprising a plurality of cDNAs which are differentially expressed in treated rat liver and in human liver and which may be used in their entirety or in part to diagnose, stage, or treat a liver disorder, to monitor diagnostic and therapeutic applications, to detect metabolic and toxicological responses, and to elucidate drug mechanism of action.Type: ApplicationFiled: December 5, 2001Publication date: September 4, 2003Inventors: Mary Jane Cunningham, Matthew R. Kaser
-
Publication number: 20030135027Abstract: The invention provides a mammalian imidazoline receptor, its encoding cDNA and an antibody that specifically binds the protein; each of which is useful to diagnose, stage, treat or monitor the progression or treatment of cancer, hypertension, immune disorder or reproductive disorder.Type: ApplicationFiled: October 29, 2002Publication date: July 17, 2003Applicant: Incyte Genomics, Inc.Inventors: Preeti G. Lal, Y. Tom Tang, Mariah R. Baughn, Matthew R. Kaser
-
Publication number: 20030108871Abstract: The present invention relates to a composition comprising a plurality of cDNAs which are differentially expressed in treated human C3A liver cell cultures and which may be used entirely or in part to diagnose, to stage, to treat, or to monitor the progression or treatment of liver disorders such as hyperlipidemia.Type: ApplicationFiled: July 30, 2001Publication date: June 12, 2003Inventor: Matthew R. Kaser
-
Publication number: 20030022254Abstract: The invention provides a mammalian nucleic acid sequence and fragments thereof. It also provides for the use of these nucleic acid sequences in a model system for the characterization, diagnosis, evaluation, treatment, or prevention of conditions, diseases and disorders associated with expression of the mammalian nucleic acid sequence. The invention additionally provides expression vectors and host cells for the production of the protein encoded by the mammalian nucleic acid sequence.Type: ApplicationFiled: September 4, 2002Publication date: January 30, 2003Applicant: Incyte Genomics, Inc.Inventors: Matthew R. Kaser, Mariah R. Baughn
-
Publication number: 20020169304Abstract: The invention provide mammalian nucleic acid molecules and fragments thereof. It also provides for the use of the mammalian nucleic acid molecules for the characterization, diagnosis, evaluation, treatment, or prevention of conditions, diseases and disorders associated with Alzheimer's disease and Down syndrome. The invention additionally provides expression vectors and host cells for the production of the protein encoded by the mammalian nucleic acid molecules.Type: ApplicationFiled: December 22, 1999Publication date: November 14, 2002Inventors: MATTHEW R. KASER, Olga Bandman, Jennifer L. Hillman, Preeti Lal, BENJAMIN G. COCKS, JEANNE LORING, Y. TOM TANG, HENRY YUE
-
Patent number: 6475752Abstract: The invention provide a mammalian nucleic acid molecule and fragments thereof. It also provides for the use of the mammalian nucleic acid molecule for the characterization, diagnosis, evaluation, treatment, or prevention of conditions, diseases and disorders associated with its expression and for the production of a model system. The invention additionally provides expression vectors and host cells for the production of the protein encoded by the mammalian nucleic acid molecule. The invention further provides a mammalian protein or portions thereof. The invention still further provides for the use of the nucleic acid molecule and protein in assays to detect or purify ligands.Type: GrantFiled: July 30, 1999Date of Patent: November 5, 2002Assignee: Incyte Genomics, Inc.Inventors: Preeti Lal, Y. Tom Tang, Mariah R. Baughn, Matthew R. Kaser
-
Patent number: 6465200Abstract: The invention provides a mammalian nucleic acid sequence and fragments thereof. It also provides for the use of these nucleic acid sequences in a model system for the characterization, diagnosis, evaluation, treatment, or prevention of conditions, diseases and disorders associated with expression of the mammalian nucleic acid sequence. The invention additionally provides expression vectors and host cells for the production of the protein encoded by the mammalian nucleic acid sequence.Type: GrantFiled: April 17, 2001Date of Patent: October 15, 2002Assignee: Incyte Genomics, Inc.Inventors: Matthew R. Kaser, Mariah R. Baughn
-
Publication number: 20020132238Abstract: The invention provides progesterone receptor complex p23-like protein and its encoding cDNA. It also provides for the use of the cDNA, protein, and antibodies in the diagnosis, prognosis, treatment and evaluation of therapies for neoplastic disorders and immune response. The invention further provides vectors and host cells for the production of the protein and transgenic model systems.Type: ApplicationFiled: May 29, 2001Publication date: September 19, 2002Inventors: Henry Yue, Matthew R. Kaser
-
Publication number: 20020106664Abstract: The invention provides a cDNA which encodes tapasin-like protein. It also provides for the use of the cDNA, protein, and antibody in the diagnosis, prognosis, treatment and evaluation of therapies for cancer. The invention further provides vectors and host cells for the production of the protein and transgenic model systems.Type: ApplicationFiled: August 20, 2001Publication date: August 8, 2002Inventors: Preeti G. Lal, Matthew R. Kaser, Mariah R. Baughn